Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ELOXX PHARMACEUTICALS, INC.

(ELOX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ELOXX PHARMACEUTICALS, INC.
2021Oppenheimer Initiates Coverage on Eloxx Pharmaceuticals With Outperform Rating, $4 Pric..
MT
2021HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $1 From $2, Keeps Neutral ..
MT
2021ELOXX PHARMACEUTICALS : Topline ELX-02 Phase 2 Results Call and Webcast
PU
2021Eloxx Pharmaceuticals' Mid-Stage Cystic Fibrosis Trial Meets Key Secondary Endpoint, Sa..
MT
2021ELOXX PHARMACEUTICALS : Reports Positive Topline Results from Monotherapy Arms of Phase 2 ..
PU
2021Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2..
AQ
2021Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2..
CI
2021HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $2 From $3, Maintains Neut..
MT
2021Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Pr..
PU
2021Eloxx Pharmaceuticals, Inc. Appoints Ali Hariri as Chief Medical Officer
CI
2021Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Pr..
AQ
2021Eloxx Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Mon..
CI
2021ELOXX PHARMACEUTICALS : Webcast and Conference Call
PU
2021ELOXX PHARMACEUTICALS : to Host Investor and Analyst Call and Webcast on Cystic Fibrosis P..
GL
2021Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital
CI
More most relevant news
All news about ELOXX PHARMACEUTICALS, INC.
01/05ELOXX PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listin..
AQ
2021Oppenheimer Initiates Coverage on Eloxx Pharmaceuticals With Outperform Rating, $4 Pric..
MT
2021HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $1 From $2, Keeps Neutral ..
MT
2021ELOXX PHARMACEUTICALS : Topline ELX-02 Phase 2 Results Call and Webcast
PU
2021Eloxx Pharmaceuticals' Mid-Stage Cystic Fibrosis Trial Meets Key Secondary Endpoint, Sa..
MT
2021ELOXX PHARMACEUTICALS : Reports Positive Topline Results from Monotherapy Arms of Phase 2 ..
PU
2021ELOXX PHARMACEUTICALS, INC. : Regulation FD Disclosure, Other Events, Financial Statements..
AQ
2021Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2..
AQ
2021Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2..
CI
2021HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $2 From $3, Maintains Neut..
MT
More news
News in other languages on ELOXX PHARMACEUTICALS, INC.
2021L'essai de phase intermédiaire d'Eloxx Pharmaceuticals sur la mucoviscidose atteint le ..
2021ELX-02 d'Eloxx Pharmaceuticals reçoit la désignation de procédure accélérée de la FDA p..
2021Eloxx Pharmaceuticals dépose un dossier mixte de 200 millions de dollars.
2021Démission du contrôleur et trésorier d'Eloxx Pharmaceuticals
2021Eloxx Pharma attend une partie des données de l'essai de mi-étape sur la mucoviscidose ..
2021Roche divulgue une participation de 5,3 % dans Eloxx Pharmaceuticals
2021Eloxx Pharmaceuticals obtient un financement de 2,6 millions de dollars pour le dévelop..
2021Les actions d'Eloxx Pharma chutent de 20 % après la fixation du prix de l'offre d'actio..
2021Les actions prolongent leur rebond en milieu de journée, les rendements du Trésor baiss..
2021RAPPORT DE LA MI-JOURNÉE : La Bourse prolonge son rebond en milieu de journée, les rendeme..
More news
Analyst Recommendations on ELOXX PHARMACEUTICALS, INC.
2021Oppenheimer Initiates Coverage on Eloxx Pharmaceuticals With Outperform Rating, $4 Pric..
MT
2021HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $1 From $2, Keeps Neutral ..
MT
2021HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $2 From $3, Maintains Neut..
MT
2021ELOXX PHARMACEUTICALS : Mizuho Securities Starts Eloxx Pharmaceuticals at Buy With $3.10 P..
MT
2021ELOXX PHARMACEUTICALS : B. Riley Starts Eloxx Pharmaceuticals at Buy with $5 PT, Notes Com..
MT
More recommendations
Press releases
01/05ELOXX PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listin..
AQ
2021ELOXX PHARMACEUTICALS : Topline ELX-02 Phase 2 Results Call and Webcast
PU
2021ELOXX PHARMACEUTICALS : Reports Positive Topline Results from Monotherapy Arms of Phase 2 ..
PU
2021ELOXX PHARMACEUTICALS, INC. : Regulation FD Disclosure, Other Events, Financial Statements..
AQ
2021Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2..
AQ
More press releases
Upcoming event on ELOXX PHARMACEUTICALS, INC.
03/10/22